Dystonia treatment in an international cohort: a longitudinal analysis
Objective: To assess the change in therapy for dystonia over time Background: Although botulinum toxin (BoNT) injections are the gold standard therapy for patients with focal…Dystonia due to bilateral caudate hemorrhage associated with a COL4A1 mutation
Objective: Pathogenic mutations of COL4A1 are associated with young-onset stroke and porencephaly. We present a case of a 32-year-old female patient with juvenile onset right hand…High intensity interval training improves psychomotor function in individuals with Parkinson’s disease
Objective: The study aimed to examine the effects of high intensity interval training (HIIT) on neurological, psychological and biomechanical aspects of psychomotor behaviors in Parkinson’s…New method to evaluate new motor skill learning
Objective: To present a novel approach to assessing improvements in new motor skill learning. Background: Several methods have been employed over the years to try…The management of Parkinson’s disease in the Middle East countries: the MDS-middle east task force survey
Objective: The movement disorders society task force for the Middle East (MDS-Task Force for the Middle East) conducted a survey with an aim of characterizing…Availability of anti-Parkinsonian drugs in Thailand
Objective: To determine the availability of two categories of anti-PD drugs in each level of healthcare facilities and region in Thailand. Background: Anti-Parkinsonian (PD) drugs…Slow Release Fixed Dose Combination of Low Doses Pramipexole and Rasagiline (P2B001) for the Treatment of Early Parkinson’s Disease (PD).
Objective: Evaluation of the efficacy and safety of a slow release low dose combination of pramipexole (PPX) and rasagiline (RAS) (P2B001) in a prospective double-blind…Ambulatory movement measurement in evaluating deep brain stimulation effect in patients with advanced Parkinson’s disease
Objective: To assess the use of the Parkinson's Kinetigraph™ (PKG™) in evaluating the effect of deep brain stimulation (DBS) in patients with advanced Parkinson's disease (PD). Background: Assessment of the effect of DBS on bradykinesia…The landscape of interventional trials in Parkinson disease: A 10-year review of ClinicalTrials.gov between 2006 and 2016
Objective: To review the scope of interventional trials for Parkinson disease registered on clinicaltrials.gov in the past 10 years. Background: Parkinson disease (PD) is a broad chronic condition…Gait Asymmetry and Parkinson’s Disease
Objective: To evaluate gait asymmetry using velocity-dependent gait analysis and compare to UPDRS asymmetries. Background: Motor impairment, including gait impairment, in patients with Parkinson’s disease…
- « Previous Page
- 1
- …
- 55
- 56
- 57
- 58
- 59
- …
- 155
- Next Page »